Personaleyes
Sydney, New South Wales, 2000, Australia
NCT Number: NCT06021353
The purpose of this study is to assess the WaveLight Ultraviolet Femtosecond Laser System, Model 1026 (UV fs-Laser) corneal flap creation accuracy as compared to the already marketed WaveLight FS200 Infrared Femtosecond Laser, Model 1025 (IR fs-Laser).
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Sydney, New South Wales, 2000, Australia
Subjects who qualify to participate will have both eyes treated in the study (one eye with the UV fs-Laser and the other eye with the IR fs-Laser) and will attend a total of 5 study visits over a period of approximately 2 months. This study will be conducted outside the United States.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Key Inclusion Criteria:
Key Exclusion Criteria:
Stationary scanning spot femtosecond laser used for corneal flap creation during refractive surgery
Other names: WaveLight Ultraviolet Femtosecond Laser Model 1026 with Patient Interface Model 1507
Stationary scanning spot femtosecond laser used for corneal flap creation during refractive surgery
Other names: WaveLight FS200 Infrared Femtosecond Laser Model 1025 with Patient Interface Model 1515
Laser-assisted in situ keratomileusis (LASIK) surgery
Time frame: Month 1
Corneal flap thickness will be measured using optical coherence tomography (OCT)
Alcon Research
Industry
Contralateral Study of the WaveLight® Ultraviolet Femtosecond Laser, Model 1026 Versus the WaveLight® FS200 Infrared Femtosecond Laser, Model 1025 for Corneal Flap Creation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07570602
Eye Diseases, Presbyopia
Bloomington, Indiana, United States
View Trial DetailsNCT07614113
Eye Diseases, Myopia
Faisalābad, Punjab Province, Pakistan
View Trial DetailsNCT06668246
Ametropia, Eye Diseases
Brest, France
View Trial DetailsNCT05059041
Abnormalities, Multiple, Chromosome Disorders
Columbus, Ohio, United States
View Trial Details